The GM of Omega Pharma Czech Republic & Slovakia reveals why the company has to position itself as reliable partner rather than a mere supplier and reviews the 32 percent growth in net sales in 2015, highlighting the significance of market segmentation, re-focusing on core assets, and the role of his staff.
You were appointed general manager for Omega Pharma Czech Republic & Slovakia shortly before the acquisition by Perrigo – what was your mandate and what expectations were made of you?
We ... increased patient education by collaborating with selected physicians and nurses. Their involvement has allowed us to create an integrated patient-physician-pharmacy model.
